Balloon Pulmonary Angioplasty for Chronic Thromboembolic Disease
Official title: Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease Without or With Mild Pulmonary Hypertension
Run by Amsterdam UMC, location VUmc · NCT06090838 · Data updated 2026-11-12
This study tests if Balloon Pulmonary Angioplasty can improve the quality of life and exercise ability for people with chronic thromboembolic pulmonary disease who don't have high blood pressure in their lungs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Amsterdam UMC, location VUmc Academic / other |
| Locations | 1 site (Amsterdam, North Holland) |
| Status | Recruiting |
| Started | June 15, 2023 |
| Main results expected | October 31, 2025 |
| Study ends | October 31, 2027 |
| Registry record updated | October 19, 2023 |
| Trial ID | NCT06090838 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18-80 with a history of acute pulmonary embolism and persistent functional limitations.
✕Probably not a fit
Patients with pulmonary hypertension or those who do not meet the specific inclusion criteria will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effects of Balloon Pulmonary Angioplasty (BPA) on quality of life and exercise capacity in patients suffering from chronic thromboembolic pulmonary disease (CTEPD) without pulmonary hypertension. It employs a randomized, cross-over design where participants will first receive BPA treatment or serve as controls, followed by assessments of their quality of life and exercise performance. The study aims to determine the therapeutic effects of BPA and the optimal timing for the intervention, using various clinical assessments and questionnaires throughout the trial period.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life and physical capabilities of patients with CTEPD.
How similar studies have gone: While there have been studies on BPA for other conditions, this specific approach for CTEPD without PH is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* acute pulmonary embolism at least 3 months prior to inclusion and adequately treated
* persistent functional limitations: (New York Heart Association (NYHA) class ≥2)
* persistent radiological perfusion defects: ≥ 3 segmental perfusion defects
* CPET result with:
1. at least 2 of the following criteria:
* peak VO2 \< 80%;
* peak O2 pulse \< 80% of predicted;
* V'E/V'CO2 @ nadir \> 34;
* Vd/Vt increasing until peak exercise or peak Vd/Vt \> 0;4;
* gradual drop of SpO2 of ≥ 3%;
2. these exercise findings cannot be explained otherwise 2. patients completed a pulmonary rehabilitation program of at least 8 weeks no longer than 2 months before randomization.
3\. exercise tests were performed after the pulmonary rehabilitation program 4. age 18-80 years 5. Clinical Frailty Scale (CFS) score \< 5 (CFS is a 9-point scale that summarizes the overall level of fitness or frailty of an older adult) 6. written informed consent 7. prior treatment or restart therapeutic dose of anticoagulation treatment before randomization
Exclusion Criteria:
1. history of balloon pulmonalis angiography (BPA) or pulmonary endarterectomy
2. residual thrombi that are not eligible for BPA
3. major acute or chronic cardiopulmonary comorbidities with an expected impact on survival, exercise capacity and/or gas exchange, e.g. significant coronary heart disease, diastolic/systolic heart failure, pulmonary hypertension (mPAP \> 25 mmHg), severe chronic obstructive pulmonary disease (COPD) GOLD class ≥3, interstitial lung disease (ILD), disabling neuromuscular disease, malignancy
4. inability to undergo exercise tests
5. contrast allergy
6. creatinine clearance \< 30ml/min
7. pregnancy or breastfeeding
Where it's running
-
Amsterdam UMC
Amsterdam, North Holland, Netherlands Recruiting
Study contacts
- Study coordinator: Aleid Breuning, MD
- Email: a.m.breuning@amsterdamumc.nl
- Phone: 0031204444444
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for patients with chronic thromboembolic disease
This study is collecting information from patients with chronic thromboembolic disease to see how different treatments affect their health and quality of life over time.
-
Using AI to improve imaging for pulmonary embolism diagnosis
This study is testing if using advanced imaging and artificial intelligence can help doctors diagnose and manage pulmonary embolism better for patients who might have it.
-
Pulmonary Embolism Registry from Emergency Care to Long-Term Follow-Up
This registry follows adults with acute pulmonary embolism to see how care is given in the real world and what happens over time.
-
Nailfold Capillaroscopy in Pulmonary Hypertension
This study tests whether nailfold capillary scans correlate with invasive lung blood pressure measurements and whether these patterns change with PH treatment.
-
How pulmonary endarterectomy affects confidence in managing chronic thromboembolic pulmonary hypertension
This project will see if pulmonary endarterectomy helps people with chronic thromboembolic pulmonary hypertension feel more confident managing their condition.
-
Registry of people with chronic thromboembolic pulmonary hypertension in Russia
This registry collects health, history, and treatment information from people in Russia with chronic thromboembolic pulmonary hypertension to see which factors relate to their prognosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.